Compounds of the formula I ** Formula ** wherein X denotes N or CR1, R1 denotes H, F, Cl, CH3, CH2OH, CH2CI, CH2Br, CF3, CHF2 or CH2F, R2 denotes H or A, Y denotes Ar1, Het1 or Cyc, Ar1 denotes phenyl or naphthyl, which is unsubstituted or mono, di or trisubstituted by Hal, A, [C (R2) 2] pOR2, [C (R2) 2] pN (R2) 2, [C ( R2) 2] pHet2, NO2, CN, [C (R2) 2] pCOOR2, [C (R2) 2] pCON (R2) 2, NR2COA, NR2SO2A, [C (R2) 2] pSO2N (R2) 2, S (O) nA, COHet3, O [C (R2) 2] mN (R2) 2, O [C (R2) 2] pAr2, O [C (R2) 2] pHet2, NHCOOA, NHCON (R2) 2, CHO and / or COA, Ar2 denotes phenyl, which is unsubstituted or that is mono or disubstituted by Hal, A, [C (R2) 2] pOR2, [C (R2) 2] pN (R2) 2, [C (R2 ) 2] pHet3, NO2, CN, [C (R2) 2] pCOOR, [C (R2) 2N (R2) 2, N (R2) 2COA, NR2SO2A, [C (R2) 2] pSO2N (R2) 2, S (O) nA, COHet3, O [C (R2) 2] mN (R2) 2, O [C (R2) 2] pHet3, NHCOOA, NHCON (R2) 2, CHO and / or COA, Het1 denotes pyrrolidinyl, azetidinyl, tetrahydroimidazolyl, tetrahydrofuranyl, tetrahydropyrazolyl, tetrahydropyranyl, piperidinyl, morpholinyl, hexahydropyridazinyl, hexahydropyrimidinyl, [1,3-dioxolanyl , Piperazinyl, furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, triazolyl, tetrazolyl, pyridyl, pyrimidyl, pyridazinyl, indolyl, isoindolyl, benzimidazolyl, indazolyl, quinolyl, 1,3-benzodioxolyl, benzothiophenyl, benzofuranyl , imidazopyridyl or furo [3,2-b] pyridyl, each of which is unsubstituted or mono or disubstituted by Hal, A, [C (R2) 2] pOR2, [C (R2) 2] pN (R2) 2, [C (R2) 2] pHet2, [C (R2) 2] pAr2, NO2, CN, [C (R2) 2] pCOOR2, [C (R2) 2] pCON (R2) 2, NR2COA, NR2SO2A, [C (R2) 2] pSO2N (R2) 2, S (O) nA, C0Het3, O [C (R2) 2] mN (R2) 2, O [C (R2) 2] pAr2, O [C (R2 ) 2] pHet2, NHCOOA, NHCON (R2) 2, CHO, COA,>； = S,>； = NR and / or>； = O, Cyc denotes cyclic alkyl with 3, 4, 5, 6 or 7 C atoms, which it may be unsubstituted or monosubstituted by A, Hal, CN or Ar2 or Het2, Het2 denotes pyrrolidinyl, azetidinyl, tetrahydroimidazolyl, tetrahyd
